Current role
Biotechnology · Healthcare
CFO
2025-08-11–present
Uneek Mehra
Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Oncology Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBOT alertsAbout Uneek Mehra
Uneek Mehra is recorded as CFO at BridgeBio Oncology Therapeutics, Inc. (BBOT) since August 11, 2025. BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed April 23, 2026 that Uneek Mehra resigned as Chief Financial Officer, effective April 21, 2026. BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed August 13, 2025 that Uneek Mehra was appointed Chief Financial Officer, effective August 11, 2025. The proxy statement of BridgeBio Oncology Therapeutics, Inc. reports total compensation of $4,555,625 for Uneek Mehra in fiscal 2025, including a base salary of $233,188. BridgeBio Oncology Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Oncology Therapeutics, Inc. includes Eli Wallace (CEO and Board Member), Pedro Beltran, Ph.D. (CEO and Board Member), Pedro J. Beltran, Ph.D. (CEO and Board Member) and 7 others.
“On April 21, 2026, Uneek Mehra, the Company’s Chief Financial Officer, departed from his roles as principal financial officer and principal accounting officer of the Company, and his last day with the Company will be April 30, 2026.”
“Uneek Mehra was appointed as PubCo's Chief Financial Officer (serving as principal financial officer and principal accounting officer)”
Affiliation history
-
Current
2025-08-11–present
-
Start not stated–2026-04-21
Company network
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Neil Kumar, Ph.D. Chairman
- Idan Elmelech CFO, COO
- Marc Cobo Chief Accounting Officer
- Albert A. Holman, III Board Member
- Bihua Chen Board Member
- Frank McCormick Board Member
- Frank P. McCormick Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | M.B.A. Former Chief Financial Officer | $233,188 | $4,555,625 |